iDNA Genomics
Personnel
- Angeliki Kapellou, Principal Investigator
Phone: 00306938406218
Email: angiekapellou@hotmail.com
Assertion criteria
Level: Assertion criteria not provided
Summary of submissions to ClinVar
Total submissions: 10
Gene
Condition
| Name | Submissions | Last Updated |
|---|---|---|
| Abnormality of immune system physiology | 1 | Jun 2, 2022 |
| Acatalasia | 1 | Jun 2, 2022 |
| Hypertensive disorder | 1 | Jun 2, 2022 |
| Inflammation | 1 | Jun 2, 2022 |
| Lactase persistence | 1 | Jun 2, 2022 |
| Microvascular complications of diabetes, susceptibility to, 6 | 1 | Jun 2, 2022 |
| Myocardial infarction, susceptibility to | 2 | Jun 2, 2022 |
| Neural tube defects, folate-sensitive | 1 | Jun 2, 2022 |
| Type 2 diabetes mellitus | 1 | Jun 2, 2022 |
Testing in GTR
| Disease name | Number of tests |
|---|---|
| Amisulpride response | 1 test |
| Amitriptyline response | 1 test |
| Aripiprazole response | 1 test |
| Carbamazepine hypersensitivity | 1 test |
| Carbamazepine response | 1 test |
| Citalopram response | 1 test |
| Clobazam response | 1 test |
| Clomipramine response | 1 test |
| Clozapine response | 1 test |
| Donepezil response | 1 test |
| Duloxetine response | 1 test |
| Escitalopram response | 1 test |
| Fluoxetine response | 1 test |
| Fluvoxamine response | 1 test |
| Galantamine Response | 1 test |
| Haloperidol response | 1 test |
| Lamotrigine response | 1 test |
| Olanzapine response | 1 test |
| Paliperidone response | 1 test |
| Paroxetine response | 1 test |
| Phenytoin toxicity | 1 test |
| Quetiapine response | 1 test |
| Risperidone response | 1 test |
| Selective serotonin reuptake inhibitor response | 1 test |
| Sertraline response | 1 test |
| Topiramate response | 1 test |
| Valproic Acid response | 1 test |
| Venlafaxine response | 1 test |
| Vortioxetine Response | 1 test |
| Ziprasidone response | 1 test |